chrX-151954708-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004961.4(GABRE):āc.1514A>Gā(p.Asn505Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000101 in 1,192,428 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.0000083 ( 0 hom. 3 hem. )
Consequence
GABRE
NM_004961.4 missense
NM_004961.4 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 4.53
Genes affected
GABRE (HGNC:4085): (gamma-aminobutyric acid type A receptor subunit epsilon) The product of this gene belongs to the ligand-gated ionic channel (TC 1.A.9) family. It encodes the gamma-aminobutyric acid (GABA) A receptor which is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes an epsilon subunit. It is mapped to chromosome Xq28 in a cluster comprised of genes encoding alpha 3, beta 4 and theta subunits of the same receptor. Alternatively spliced transcript variants have been identified, but only one is thought to encode a protein. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRE | NM_004961.4 | c.1514A>G | p.Asn505Ser | missense_variant | 9/9 | ENST00000370328.4 | NP_004952.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRE | ENST00000370328.4 | c.1514A>G | p.Asn505Ser | missense_variant | 9/9 | 1 | NM_004961.4 | ENSP00000359353 | P1 | |
GABRE | ENST00000486255.1 | n.4593A>G | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
GABRE | ENST00000483564.5 | n.1164A>G | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000270 AC: 3AN: 111111Hom.: 0 Cov.: 23 AF XY: 0.0000600 AC XY: 2AN XY: 33353
GnomAD3 genomes
AF:
AC:
3
AN:
111111
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33353
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000319 AC: 5AN: 156945Hom.: 0 AF XY: 0.0000213 AC XY: 1AN XY: 46983
GnomAD3 exomes
AF:
AC:
5
AN:
156945
Hom.:
AF XY:
AC XY:
1
AN XY:
46983
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000832 AC: 9AN: 1081317Hom.: 0 Cov.: 30 AF XY: 0.00000854 AC XY: 3AN XY: 351249
GnomAD4 exome
AF:
AC:
9
AN:
1081317
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
351249
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000270 AC: 3AN: 111111Hom.: 0 Cov.: 23 AF XY: 0.0000600 AC XY: 2AN XY: 33353
GnomAD4 genome
AF:
AC:
3
AN:
111111
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33353
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2024 | The c.1514A>G (p.N505S) alteration is located in exon 9 (coding exon 9) of the GABRE gene. This alteration results from a A to G substitution at nucleotide position 1514, causing the asparagine (N) at amino acid position 505 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Gain of disorder (P = 0.2964);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at